← All trials
NCT03063515
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 19, 2017
- Primary completion
- Sep 30, 2017
- Completion date
- Sep 30, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 12
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of MiamiLead sponsor
- University of MiamiOverall official - principal investigator
- University of MiamiReponsible party - principal investigator
- American Diabetes AssociationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.